European Partnership on Personalised Medicine

Last updated: 21.7.2025
Grant

The European Partnership on Personalised Medicine, funded under Horizon Europe, is a key initiative designed to transform healthcare by advancing tailored medical approaches. This program aimed to foster collaborative research and innovation to ensure equitable access to sustainable, high-quality healthcare across Europe and beyond. It distinguishes itself by integrating diverse stakeholders and focusing on the swift translation of research into clinical practice and market solutions.

Who is Funded

This section details the entities and geographical areas eligible for the European Partnership on Personalised Medicine, outlining the program's strategic objectives to advance innovative, sustainable, and high-quality healthcare through collaborative efforts.

What is Funded

This section outlines the types of projects and thematic areas supported by the European Partnership on Personalised Medicine, detailing the scope of eligible activities and the development stages of projects it aimed to advance. The program focused on research, development, and implementation of personalised medicine solutions.

Type and Scope of Funding

This section details the financial structure of the European Partnership on Personalised Medicine, including the type of financial instrument used and the maximum funding available per project or to third parties.

Conditions and Requirements

This section outlines the essential conditions and requirements for participation in the European Partnership on Personalised Medicine, covering various stipulations from application terms to collaboration structures and budget rules.

Application Procedure

This section details the application process and evaluation mechanisms for the European Partnership on Personalised Medicine, including submission timelines and how proposals were assessed.

This section details the foundational legal and official documents governing the European Partnership on Personalised Medicine, ensuring its legitimacy and outlining the regulations that shape its implementation and funding.

Similar Programs

#Personalised Medicine#Health Research#Horizon Europe#Healthcare Innovation#EU Funding#Health Systems#Digital Health#Disease Prevention#Medical Technology#Public Health Policy#Clinical Applications#Research Partnerships#Data Economy#Patient-Centred Care#Sustainable Healthcare#International Cooperation#Capacity Building#Medical Ethics#Oncology#Human Genetics

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

100,000,000 €

Deadline

Deadline:

13.04.2023

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union, United States of America, Other

Sectors

Sectors:

Healthcare, Medical Technology, Research and Development, Information and Communication Technology

Beneficiaries

Beneficiaries:

Health sector, healthcare systems, patients, citizens, healthcare providers, informal carers, health industries, policymakers.

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Applied Research, Pilot Testing, Market Introduction, Implementation, Service Delivery, Capacity Building, Awareness Campaigns

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

0 x 0
XS